Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 11349-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#11349-1-AP, RRID:AB_2220001
- Product name
- ABAT antibody
- Antibody type
- Polyclonal
- Description
- ABAT antibody (Cat. #11349-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Neurotransmitter accumulation and Parkinson's disease-like phenotype caused by anion channelrhodopsin opto-controlled astrocytic mitochondrial depolarization in substantia nigra pars compacta.
TRPV1 inhibition suppresses non-small cell lung cancer progression by inhibiting tumour growth and enhancing the immune response.
Integrative Analysis Developing and Validating Potential Candidate Biomarkers for Cancer Stemness Features of Pan-Renal Cell Carcinoma.
EphB6 deficiency in intestinal neurons promotes tumor growth in colorectal cancer by neurotransmitter GABA signaling.
Cancer-cell-derived GABA promotes β-catenin-mediated tumour growth and immunosuppression.
Neuronal gamma-aminobutyric acid (GABA) type A receptors undergo cognate ligand chaperoning in the endoplasmic reticulum by endogenous GABA.
Li SM, Wang DD, Liu DH, Meng XY, Wang Z, Guo X, Liu Q, Liu PP, Li SA, Wang S, Yang RZ, Xu Y, Wang L, Kang JS
MedComm 2024 Jun;5(6):e568
MedComm 2024 Jun;5(6):e568
TRPV1 inhibition suppresses non-small cell lung cancer progression by inhibiting tumour growth and enhancing the immune response.
Wang Y, Zhang Y, Ouyang J, Yi H, Wang S, Liu D, Dai Y, Song K, Pei W, Hong Z, Chen L, Zhang W, Liu Z, Mcleod HL, He Y
Cellular oncology (Dordrecht, Netherlands) 2024 Jun;47(3):779-791
Cellular oncology (Dordrecht, Netherlands) 2024 Jun;47(3):779-791
Integrative Analysis Developing and Validating Potential Candidate Biomarkers for Cancer Stemness Features of Pan-Renal Cell Carcinoma.
Lin F, Ke ZB, Chen H, Zheng WC, Dong RN, Cai H, Li XD, Wei Y, Zheng QS, Xue XY, Chen SH, Xu N
Cancer investigation 2023 May;41(5):495-511
Cancer investigation 2023 May;41(5):495-511
EphB6 deficiency in intestinal neurons promotes tumor growth in colorectal cancer by neurotransmitter GABA signaling.
Yu H, Qin XK, Yin KW, Li ZM, Ni ED, Yang JM, Liu XH, Zhou AJ, Li SJ, Gao TM, Li Y, Li JM
Carcinogenesis 2023 Dec 2;44(8-9):682-694
Carcinogenesis 2023 Dec 2;44(8-9):682-694
Cancer-cell-derived GABA promotes β-catenin-mediated tumour growth and immunosuppression.
Huang D, Wang Y, Thompson JW, Yin T, Alexander PB, Qin D, Mudgal P, Wu H, Liang Y, Tan L, Pan C, Yuan L, Wan Y, Li QJ, Wang XF
Nature cell biology 2022 Feb;24(2):230-241
Nature cell biology 2022 Feb;24(2):230-241
Neuronal gamma-aminobutyric acid (GABA) type A receptors undergo cognate ligand chaperoning in the endoplasmic reticulum by endogenous GABA.
Wang P, Eshaq RS, Meshul CK, Moore C, Hood RL, Leidenheimer NJ
Frontiers in cellular neuroscience 2015;9:188
Frontiers in cellular neuroscience 2015;9:188
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- human liver tissue were subjected to SDS PAGE followed by western blot with 11349-1-AP(ABAT antibody) at dilution of 1:300
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The ABAT antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human ABAT. This antibody recognizes human, mouse, rat antigen. The ABAT antibody has been validated for the following applications: ELISA, WB, IHC analysis.